相关实验视频
Updated: Feb 20, 2026

08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
17.0K
选择性抑制FOXO1激活剂/抑制剂平衡调节肝脏葡萄糖处理
Fanny Langlet1, Rebecca A Haeusler2, Daniel Lindén3
1Naomi Berrie Diabetes Center, Columbia University, New York, NY 10032, USA; Department of Medicine, Columbia University, New York, NY 10032, USA.
Cell
|October 24, 2017
概括
研究人员确定SIN3A是胰岛素抵抗的一个关键因素,发现了一种潜在的新方法来治疗糖尿病,通过选择性地准葡萄糖的产生而不会导致脂肪的积累.
科学领域:
- 分子生物学
- 代谢疾病
- 内分泌学
背景情况:
- 胰岛素耐药性是糖尿病的核心特征,具有重大临床挑战.
- 胰岛素通过抑制肝脏葡萄糖的产生和通过FOXO1促进脂质生成来调节葡萄糖代谢.
- 胰岛素对葡萄糖生产和脂质生成的双重作用造成了治疗困境.
研究的目的:
- 为了确定未知的FOXO1核抑制剂的葡萄糖酶.
- 研究选择性抑制肝脏葡萄糖产生的治疗策略.
- 开发具有减少脂质效应的新型胰岛素敏感剂.
主要方法:
- 通过分子查确定SIN3A为胰岛素敏感的FOXO1核心抑制剂.
- 利用SIN3A的遗传切除来评估其在营养调节和葡萄糖代谢中的作用.
- 进行小分子查,以发现选择性抑制FOXO1-依赖葡萄糖的产生.
主要成果:
- SIN3A被确定为葡萄糖酶的FOXO1核心抑制剂,它调解胰岛素对该酶的作用.
- SIN3A的遗传删除破坏了葡萄酶的营养调节,但没有影响其他FOXO1标.
- 通过SIN3A切除,降低了血糖水平,但没有诱导肝脂肪症.
- 发现了FOXO1依赖性葡萄糖生成的选择性抑制剂,缺乏肝细胞中的脂肪生成活性.
结论:
- SIN3A是胰岛素对肝脏葡萄糖产生和葡萄糖激酶调节的关键调解剂.
- 通过向SIN3A或相关途径,通过降低葡萄糖而不产生不良脂质效应来管理糖尿病的潜在策略.
- 对非结合转录因子的选择性调节剂的开发可以克服当前胰岛素敏感剂的局限性.
相关概念视频
Glucose Homeostasis: Regulation of Blood Glucose
4.6K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.6K
Cell Specific Gene Expression
16.7K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.7K
Regulation of Metabolism
11.8K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
11.8K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.7K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.7K
Hormones Regulating Blood Glucose
7.2K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.2K
Insulin: The Receptor and Signaling Pathways
3.7K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.7K

